SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-029832
Filing Date
2023-08-22
Accepted
2023-08-22 16:30:18
Documents
1
Period of Report
2023-07-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1523
  Complete submission text file 0001493152-23-029832.txt   2882
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Issuer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOFRONTERA INC. 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address
Lanckriet Heikki (Reporting) CIK: 0001990267 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40943 | Film No.: 231193906